Compared with tumors without ALAL-1 amplification, lung adenocarcinomas with amplified ALAL-1 presented significantly lower levels of several immune populations, such as T memory, T follicular helper, and dendritic cells (Fig. 7 C). This evidence concerns the gene IKBKB-DT and lung adenocarcinoma.